Arcutis Biotherapeutics Inc (ARQT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,714 | -11,295 | -16,141 | -33,536 | -40,946 |
| Depreciation Amortization | 720 | 380 | 2,573 | 1,999 | 1,988 |
| Accounts receivable | -8,934 | 1,852 | -73,163 | -42,050 | -33,621 |
| Accounts payable and accrued liabilities | -5,923 | 5,613 | -1,694 | -8,425 | 863 |
| Other Working Capital | -14,440 | 1,789 | -34,829 | -32,503 | -12,559 |
| Other Operating Activity | 39,741 | 3,900 | 117,629 | 82,705 | 54,219 |
| Operating Cash Flow | $14,878 | $2,239 | $-5,625 | $-31,810 | $-30,056 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -26,398 | -11,332 | -19,567 | 14,612 | 39,859 |
| PPE Investments | -158 | N/A | -686 | -686 | -686 |
| Purchase Sale Intangibles | N/A | N/A | -10,000 | -10,000 | -10,000 |
| Other Investing Activity | 0 | 0 | -10,000 | -10,000 | -10,000 |
| Investing Cash Flow | $-26,556 | $-11,332 | $-30,253 | $3,926 | $29,173 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -1,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 4,057 | 1,067 | 6,973 | 3,251 | 1,775 |
| Financing Cash Flow | $3,057 | $1,067 | $6,973 | $3,251 | $1,775 |
| Exchange Rate Effect | -165 | -119 | 168 | 109 | 204 |
| Beginning Cash Position | 43,215 | 43,215 | 71,952 | 71,952 | 71,952 |
| End Cash Position | 34,429 | 35,070 | 43,215 | 47,428 | 73,048 |
| Net Cash Flow | $-8,786 | $-8,145 | $-28,737 | $-24,524 | $1,096 |
| Free Cash Flow | |||||
| Operating Cash Flow | 14,878 | 2,239 | -5,625 | -31,810 | -30,056 |
| Capital Expenditure | -158 | 0 | -686 | -686 | -686 |
| Free Cash Flow | 14,720 | 2,239 | -6,311 | -32,496 | -30,742 |